The hemostatic abnormalities commonly encountered in patients with renal disease can
significantly threaten the well-being of the patient and pose difficult management issues for …

Background Regional citrate anticoagulation (RCA) may be a valuable alternative to
systemic heparin anticoagulation during continuous venovenous hemodialysis (CVVH) …

Methods Regional heparinization (RH) was performed by the method of Spencer et al [8]
monitoring hepann therapy with at least 0.5 hourly thrombin clotting times (TCT)[9, 10] …

The risk of worsening or commencement of bleeding in high-risk patients requiring
hemodialysis has not been established. The present study of 300 dialyses in 51 patients …

A comparison between the use of recombinant hirudin and heparin during hemodialysis.
The purpose of this study was to determine the anticoagulant and antithrombotic potential of …

Hemodialysis is only possible on a routine basis if the tendency for blood to clot when in
contact with foreign surfaces is inhibited. Early attempts at extracorporeal circulation used …

For decades, the use of unfractionated heparin (UFH) has been the basic principle of
anticoagulation in patients at risk of or with established thromboembolic disorders …

A prospective comparison of three argatroban treatment regimens during hemodialysis in
end-stage renal disease. Background We prospectively evaluated 3 treatment regimens of …

The purpose of this study was to evaluate the efficacy and safety of danaparoid in the
treatment of critically ill patients with acute renal failure and suspected heparin-induced …

Cardiovascular diseases are highly prevalent among patients on dialysis. For these
diseases, antiplatelets and antithrombotic therapies including heparin, vitamin K …